147 related articles for article (PubMed ID: 20167595)
21. Non-vena cava venous leiomyosarcomas: a review of the literature.
Gage MJ; Patel AV; Koenig KL; Newman E
Ann Surg Oncol; 2012 Oct; 19(11):3368-74. PubMed ID: 22618717
[TBL] [Abstract][Full Text] [Related]
22. Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas?
Cooley CL; Jagannathan JP; Kurra V; Tirumani SH; Saboo SS; Ramaiya NH; Shinagare AB
J Comput Assist Tomogr; 2014; 38(5):687-92. PubMed ID: 24834891
[TBL] [Abstract][Full Text] [Related]
23. Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes.
Mann GN; Mann LV; Levine EA; Shen P
Surgery; 2012 Feb; 151(2):261-7. PubMed ID: 21176932
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy.
Penel N; Italiano A; Isambert N; Bompas E; Bousquet G; Duffaud F;
Ann Oncol; 2010 Jun; 21(6):1361-1365. PubMed ID: 19880438
[TBL] [Abstract][Full Text] [Related]
25. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract][Full Text] [Related]
26. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
27. Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature.
Mohanty SK; Balani JP; Parwani AV
Urology; 2007 Sep; 70(3):591.e5-7. PubMed ID: 17905130
[TBL] [Abstract][Full Text] [Related]
28. Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases.
Farshid G; Pradhan M; Goldblum J; Weiss SW
Am J Surg Pathol; 2002 Jan; 26(1):14-24. PubMed ID: 11756765
[TBL] [Abstract][Full Text] [Related]
29. Peripheral artery leiomyosarcoma.
Sakpal SV; Mehta R; Babel N; Chamberlain RS
J Vasc Surg; 2009 Jan; 49(1):217-21. PubMed ID: 19174258
[TBL] [Abstract][Full Text] [Related]
30. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
31. Leiomyosarcoma: Prognostic outline of a rare head and neck malignancy.
Saluja TS; Iyer J; Singh SK
Oral Oncol; 2019 Aug; 95():100-105. PubMed ID: 31345375
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
33. Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Italiano A; Lagarde P; Brulard C; Terrier P; Laë M; Marques B; Ranchere-Vince D; Michels JJ; Trassard M; Cioffi A; Piperno-Neumann S; Chevreau C; Blay JY; Delcambre C; Isambert N; Penel N; Bay JO; Bonvalot S; Le Cesne A; Coindre JM; Chibon F
Clin Cancer Res; 2013 Mar; 19(5):1190-6. PubMed ID: 23329812
[TBL] [Abstract][Full Text] [Related]
34. Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung.
Mentzer SJ; Antman KH; Attinger C; Shemin R; Corson JM; Sugarbaker DJ
J Surg Oncol; 1993 May; 53(1):54-9. PubMed ID: 8479198
[TBL] [Abstract][Full Text] [Related]
35. Leiomyosarcoma of the inferior vena cava.
Sulpice L; Rayar M; Levi Sandri GB; de Wailly P; Henno S; Turner K; Lesimple T; Boudjema K; Meunier B
J Visc Surg; 2016 Jun; 153(3):161-5. PubMed ID: 26711879
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
[TBL] [Abstract][Full Text] [Related]
38. Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites.
Hines OJ; Nelson S; Quinones-Baldrich WJ; Eilber FR
Cancer; 1999 Mar; 85(5):1077-83. PubMed ID: 10091791
[TBL] [Abstract][Full Text] [Related]
39. Somatic Leiomyosarcoma of the Soft Tissues: A Single-Institutional Analysis of Factors Predictive of Survival in 164 Patients.
Harati K; Daigeler A; Lange K; Niggemann H; Stricker I; Steinau HU; Lehnhardt M; Goertz O
World J Surg; 2017 Jun; 41(6):1534-1541. PubMed ID: 28116485
[TBL] [Abstract][Full Text] [Related]
40. Leiomyosarcoma of the popliteal artery: case report and review of the literature.
Caldarelli GF; Barellini L; Faviana P; Guerra M
J Vasc Surg; 2003 Jan; 37(1):206-9. PubMed ID: 12514603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
